R97.20
Elevated prostate specific antigen [PSA]
Clinical Classification Guidelines
Medical Intelligence & Overview
Elevated prostate specific antigen (PSA) refers to higher-than-normal levels of PSA in the blood. PSA is a protein produced by the prostate gland, and its levels can be measured through a simple blood test. While an increase in PSA levels can sometimes indicate prostate issues such as inflammation or benign conditions, it also can be an early sign of prostate cancer. Monitoring PSA levels is an essential part of prostate health screening, especially for men over 50 or those at increased risk of prostate problems.
Causes & Symptoms
Clinical Causes: Prostate infection or inflammation (prostatitis) Benign prostatic hyperplasia (BPH), an enlarged prostate Recent prostate surgery or procedures Urinary tract infections or urinary retention Prostate cancer Ejaculation shortly before the blood test Certain medical conditions affecting the prostate Age-related changes in prostate tissue
Key Symptoms: No noticeable symptoms in early stages Frequent urination, especially at night Difficulty starting or stopping urination Weak or interrupted urine flow Pain or burning sensation during urination Blood in urine or semen Discomfort or pain in the pelvic area or lower back Unexplained weight loss in advanced cases
Diagnostic & Treatment
Diagnosis Path: The process begins with a PSA blood test that measures the level of PSA in the bloodstream. Elevated PSA levels prompt further evaluation, which might include digital rectal examination (DRE) and imaging tests such as ultrasound or MRI. In some cases, a prostate biopsy may be performed to determine whether cancer cells are present. The combination of PSA levels, symptom assessment, physical examination, and additional tests helps healthcare providers identify the underlying cause of the elevated PSA.
Treatment Protocols: Management of elevated PSA depends on the underlying reason. When caused by benign conditions like prostatitis or BPH, treatment may involve medications such as antibiotics, alpha-blockers, or 5-alpha-reductase inhibitors. If prostate cancer is diagnosed, options could include surgery, radiation therapy, hormone therapy, or active surveillance. Lifestyle modifications, regular monitoring, and follow-up tests are often part of ongoing care. It is essential to consult with a healthcare professional to determine the most appropriate approach based on individual health status and diagnostic findings.
Clinical Advice & FAQs
Billing Guidance
Is R97.20 a billable ICD-10 code?
Yes, R97.20 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report R97.20?
Clinical documentation must specify the nature of Elevated prostate specific antigen [PSA] and any associated comorbidities for accurate reporting.
Cite this Clinical Reference